Deutsche Bank Aktiengesellschaft Lowers The Cigna Group (NYSE:CI) Price Target to $394.00

The Cigna Group (NYSE:CI) had its target price cut by stock analysts at Deutsche Bank Aktiengesellschaft from $398.00 to $394.00 in a research report issued on Monday, Benzinga reports. The firm currently has a “buy” rating on the health services provider’s stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 25.93% from the company’s previous close.

CI has been the topic of several other reports. JPMorgan Chase & Co. increased their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Stephens reissued an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday. Royal Bank of Canada dropped their price objective on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Jefferies Financial Group raised their price objective on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $394.00.

The Cigna Group Trading Down 1.1 %

Shares of The Cigna Group stock traded down $3.61 during mid-day trading on Monday, hitting $312.88. 666,184 shares of the stock were exchanged, compared to its average volume of 1,522,473. The company has a 50-day simple moving average of $345.77 and a 200 day simple moving average of $341.48. The company has a current ratio of 0.72, a quick ratio of 0.71 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $87.47 billion, a price-to-earnings ratio of 29.52, a price-to-earnings-growth ratio of 0.95 and a beta of 0.51. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.77 EPS. Research analysts forecast that The Cigna Group will post 28.48 EPS for the current year.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now owns 17,539 shares in the company, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.60% of the stock is currently owned by insiders.

Institutional Trading of The Cigna Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. Van ECK Associates Corp boosted its stake in The Cigna Group by 4.4% in the second quarter. Van ECK Associates Corp now owns 14,872 shares of the health services provider’s stock valued at $4,916,000 after acquiring an additional 625 shares during the period. Hancock Whitney Corp increased its position in The Cigna Group by 75.6% in the first quarter. Hancock Whitney Corp now owns 3,783 shares of the health services provider’s stock worth $1,374,000 after buying an additional 1,629 shares during the period. ORG Partners LLC bought a new stake in The Cigna Group in the second quarter valued at $489,000. Tidal Investments LLC boosted its holdings in shares of The Cigna Group by 36.0% during the first quarter. Tidal Investments LLC now owns 15,276 shares of the health services provider’s stock valued at $5,548,000 after acquiring an additional 4,043 shares during the period. Finally, Cetera Advisors LLC grew its position in shares of The Cigna Group by 166.6% during the first quarter. Cetera Advisors LLC now owns 25,771 shares of the health services provider’s stock worth $9,360,000 after acquiring an additional 16,103 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.